Chung-Hak Cha
Chief Executive Officer bei HUMASIS CO. LTD.
Profil
Chung-Hak Cha currently works at HUMASIS Co., Ltd., as Chief Executive Officer & Director from 2017.
Mr. Cha also formerly worked at Humasis Co., Ltd., as Chief Executive Officer and HI Special Purpose Acquisition Co. II, as Director.
Mr. Cha received his graduate degree from Korea University.
Aktive Positionen von Chung-Hak Cha
| Unternehmen | Position | Beginn |
|---|---|---|
| HUMASIS CO. LTD. | Chief Executive Officer | 28.09.2017 |
Ehemalige bekannte Positionen von Chung-Hak Cha
| Unternehmen | Position | Ende |
|---|---|---|
HI Special Purpose Acquisition Co. II
 HI Special Purpose Acquisition Co. II Financial ConglomeratesFinance HI Special Purpose Acquisition Co. II engages in merging and acquiring other companies of growth-oriented industries. The company was founded on August 29, 2014 and is headquartered in Seoul, South Korea. | Director/Board Member | - |
Humasis Co., Ltd. /Old/
 Humasis Co., Ltd. /Old/ Medical SpecialtiesHealth Technology Humasis Co., Ltd. develops rapid test kits and point-of-care testing instruments. The firm's products include test kit for fertility hormone, pregnancy, cadiac and tumor marker, infection, and continine. The company was founded in June 2000 and is headquartered in Anyang, South Korea. | Chief Executive Officer | - |
Ausbildung von Chung-Hak Cha
| Korea University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HUMASIS CO. LTD. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Humasis Co., Ltd. /Old/
Humasis Co., Ltd. /Old/ Medical SpecialtiesHealth Technology Humasis Co., Ltd. develops rapid test kits and point-of-care testing instruments. The firm's products include test kit for fertility hormone, pregnancy, cadiac and tumor marker, infection, and continine. The company was founded in June 2000 and is headquartered in Anyang, South Korea. | Health Technology |
HI Special Purpose Acquisition Co. II
HI Special Purpose Acquisition Co. II Financial ConglomeratesFinance HI Special Purpose Acquisition Co. II engages in merging and acquiring other companies of growth-oriented industries. The company was founded on August 29, 2014 and is headquartered in Seoul, South Korea. | Finance |
